Curcumin–cisplatin chemotherapy: A novel strategy in promoting chemotherapy efficacy and reducing side effects

Author:

Hussain Yaseen12,Islam Lubna3,Khan Haroon2ORCID,Filosa Rosanna4,Aschner Michael5,Javed Saba6

Affiliation:

1. Lab of Controlled Release and Drug Delivery System, College of Pharmaceutical Sciences Soochow University Suzhou China

2. Department of Pharmacy Abdul Wali Khan University Mardan Mardan Pakistan

3. Department of Pharmacy University of Malakand Dir Lower Chakdara, KPK Pakistan

4. Department of Experimental Medicine University of Campania, “L. Vanvitelli” Naples Italy

5. Department of Molecular Pharmacology Albert Einstein College of Medicine Bronx New York USA

6. Department of Zoology Hazara University Mansehra Pakistan

Publisher

Wiley

Subject

Pharmacology

Reference150 articles.

1. DNA damage response and resistance of cancer stem cells

2. An overview of cancer treatment modalities;Abbas Z.;Neoplasma,2018

3. Synergistic Roles of Curcumin in Sensitising the Cisplatin Effect on a Cancer Stem Cell-Like Population Derived from Non-Small Cell Lung Cancer Cell Lines

4. Critical Review on Curcumin as a Therapeutic Agent: From Traditional Herbal Medicine to an Ideal Therapeutic Agent

5. Curcumin induces re‐expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines;Al‐Yousef N.;Oncology Reports,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3